HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Epstein-Barr virus-associated lymphoproliferative disease after a cord blood transplant for Diamond-Blackfan anemia.

Abstract
A 7-year-old boy with Diamond-Blackfan anemia (DBA) developed lymphoproliferative disease (LPD) after a cord blood transplant (CBT). 3.1 x 107/kg mononuclear cells from an HLA one-locus mismatched CB were transplanted after conditioning with total body irradiation (8 Gy), cyclophosphamide (200 mg/kg) and antithymocyte globulin (10 mg/kg). Complete engraftment occurred on day 33 post transplant. Despite the resolution of grade II graft-versus-host disease (GVHD), he died of lymphoma on day 130 post transplant. The tumor was of donor origin, indicating clonal proliferation of Epstein-Barr virus (EBV)-infected B cells. This is the first report of EBV-LPD after CBT. Post-transplant LPD can be a serious EBV-associated complication of CB grafts. Bone Marrow Transplantation (2000) 25, 209-212.
AuthorsS Ohga, Y Kanaya, H Maki, H Takada, K Ohshima, M Kanda, A Nomura, A Suminoe, A Matsuzaki, T Hara
JournalBone marrow transplantation (Bone Marrow Transplant) Vol. 25 Issue 2 Pg. 209-12 (Jan 2000) ISSN: 0268-3369 [Print] England
PMID10673683 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Blood Component Transfusion (adverse effects)
  • Child
  • Epstein-Barr Virus Infections (blood, etiology, transmission, virology)
  • Fanconi Anemia (blood, complications, therapy, virology)
  • Fatal Outcome
  • Female
  • Fetal Blood (cytology, immunology, virology)
  • Fetal Tissue Transplantation (adverse effects, immunology)
  • Graft Survival
  • Graft vs Host Disease (etiology, immunology)
  • Hematopoietic Stem Cell Transplantation (adverse effects)
  • Herpesvirus 4, Human (physiology)
  • Histocompatibility Testing
  • Humans
  • Lymphoma, B-Cell (blood, etiology, virology)
  • Male
  • Transplantation Conditioning (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: